US Patent Issued to GUANGZHOU ENMAI BIOTECHNOLOGY on Nov. 18 for "Diagnosis and treatment for chronic inflammation and virus infection" (Chinese Inventors)

ALEXANDRIA, Va., Nov. 18 -- United States Patent no. 12,473,352, issued on Nov. 18, was assigned to GUANGZHOU ENMAI BIOTECHNOLOGY Co. LTD. (Guangzhou, China).

"Diagnosis and treatment for chronic inflammation and virus infection" was invented by Huanhuan Liang (Guangzhou, China), Yingfang Liu (Guangzhou, China) and Yang Yu (Guangzhou, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present application provides a diagnosis and treatment method for chronic inflammation. The technical solution provided by the present application is an application of a reagent in preparing a product for preventing and/or treating chronic inflammation diseases: the reagent is a substance for inhibiting the activity of an...